Mouhand F. Mohamed, MD, MSc

Mayo Clinic

Poster(s):

• P2393 - Impact of GLP-1 Agonist Versus Opioid Use on Esophagogastroduodenoscopy (EGD) Outcomes: A Propensity-Matched Analysis of the U.S. Collaborative Network
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET

• P2616 - Pneumococcal Vaccine is Associated with Improved Outcomes in Inflammatory Bowel Disease: Insights From a Propensity-Matched Study in the United States
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET

• P2617 - No Differences in Dysplasia Detection Between Dye and Virtual Chromoendoscopy Techniques: Results From a Meta-Analysis of Randomized Clinical Trials
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET

• P2618 - Polypharmacy in Inflammatory Bowel Disease: Systematic Review and Meta-analysis
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET

• P3200 - Pneumococcal Vaccine is Associated with Better Outcomes in Celiac Disease Patients: Insights From a Propensity-Matched Study in the United States
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET